A platform that uses in situ genotyping and AI to test thousands of cell therapy perturbations simultaneously in vivo, enabling ranking of designs based on spatial biology phenotyping.

A development program focused on creating cell therapies for difficult-to-treat cancers such as gastric, GE junction, and pancreatic cancers.